PGNX : Summary for Progenics Pharmaceuticals Inc. - Yahoo Finance

U.S. Markets closed

Progenics Pharmaceuticals, Inc. (PGNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.89-0.01 (-0.11%)
At close: 4:00PM EST

8.89 0.00 (0.00%)
After hours: 4:31PM EST

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close8.90
Bid8.55 x 2000
Ask9.50 x 2000
Day's Range8.78 - 8.99
52 Week Range3.61 - 9.78
Avg. Volume1,232,412
Market Cap622.76M
PE Ratio (TTM)57.35
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube4 hours ago

    ETFs with exposure to Progenics Pharmaceuticals, Inc. : January 20, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Progenics Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PGNX-US. Comparing the performance and risk of Progenics Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • TheStreet.com17 days ago

    My Top 2017 Pick: Progenics Pharmaceuticals

    This biopharma company's Relistor drug should send revenues sharply higher this year.

  • MarketWatch29 days ago

    Progenics shares rally as prostate cancer imaging study to continue

    Progenics Pharmaceuticals Inc. shares rallied in the extended session Thursday after the cancer drug company said its clinical trial of a prostate cancer imaging agent will continue. Progenics shares surged ...